BioVinc
PrivateLast Round
Grant
Mar 3, 2023
Total Funding Raised
$7.2M
Company Overview
BioVinc is a biotechnology company that develops bone-targeted therapeutics and diagnostic molecular probes for the treatment of bone diseases and infections.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Data as a Service
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioVinc Comparables
Compare BioVinc with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| MBC Pharma, Inc. | 92% | |
| Atlanthera | 90% | |
| Mesentech Inc. | 85% | |
BioVinc Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 3, 2023 | ||||
| Grant | Aug 21, 2015 |
BioVinc Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Allergy and Infectious Diseases | Grant |
| NIH RADx | Grant |
| National Institute of Dental and Craniofacial Research | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 6, 2026
Monthly visitors increased 59% MoM.
- Mar 3, 2023
$1.28M grant from National Institute of Allergy and Infectious Diseases and NIH RADx.
BioVinc Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about BioVinc's valuation, stock price, and market status.